Verdict Medical Devices is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X
Analysis

April’s top stories: Zimmer’s $13.35bn deal, FDA clears first HPV test

Zimmer signed a definitive agreement to acquire Biomet in a $13.35bn deal, while the USFDA cleared the first human papillomavirus test for primary cervical cancer screening. Medicaldevice-network.com wraps-up the key headlines from April 2014.

Go Top